Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Operating Leases (2024 - 2025)

Upstream Bio has reported Operating Leases over the past 2 years, most recently at $549000.0 for Q4 2025.

  • Quarterly results put Operating Leases at $549000.0 for Q4 2025, down 51.42% from a year ago — trailing twelve months through Dec 2025 was $549000.0 (down 51.42% YoY), and the annual figure for FY2025 was $549000.0, down 51.42%.
  • Operating Leases for Q4 2025 was $549000.0 at Upstream Bio, down from $703000.0 in the prior quarter.
  • Over the last five years, Operating Leases for UPB hit a ceiling of $1.3 million in Q3 2024 and a floor of $549000.0 in Q4 2025.